Segments Covered in this Dental Bone Graft Substitutes Procedure Volume Research
This market study focuses specifically on the volume of procedures in the dental bone graft substitutes market. It includes analysis of procedures in the following segments:

Dental Implants Placed
Dental Implants Placed with DBGS
Average Volume of DBGS used per Implant Placed

This data is then displayed over the forecast period, 2013-2023, outlining the exact growth rates for procedures in these segments. If you’re interested in seeing the trends in procedures to formulate your market sizing and forecasts this is the most accurate and most affordable way to do it.

About Procedure Volume Research (MedPro)
Our analysts meticulously research for 3 to 4 months to put together a suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedPro is one portion of that analysis that outlines only the procedure volumes and forecasts for each market in that suite of reports.

This procedural analysis is incorporated in our market size analysis and forecasting which are available when purchasing a MedSuite, MedView or MedCore. For a deeper description on these product types click here or contact us to have a product consultant help you find the data you need.

Where Do We Get Dental Bone Graft Substitutes Procedure Data?
Our team of analysts has proprietary data that we’ve been collecting for over a decade as well as government and private databases like that from CMS and hospital records. By looking at multiple sources we are able to triangulate on dental bone graft substitutes procedure volumes that influence and coincide with our overall market sizing.

Trends Affecting the Dental Bone Graft Substitutes Market
Despite the fact that autograft procedures are becoming less popular, they still account for a considerably large portion of dental bone grafting procedures across Europe. As a result, the dental biomaterial market is significantly underdeveloped in Europe, relative to the U.S. market. A prevailing preference for xenograft materials characterizes the dental bone graft substitute market in Europe and very few regions have demonstrated a shift towards allograft materials. It is expected that stringent regulations and protocols set in place by the European Tissue and Cells Directive (EUTCD) will continue to limit the allograft market and overall dental biomaterial market in the future. Other notable developments in the European dental biomaterial market include strategic partnerships between implant companies and biomaterial companies, increasing penetration of allograft materials and the introduction of innovative products that use new materials and composites of existing products.

Questions This Report will Help You Answer
What is affecting the volume of procedures in Europe?
How many procedures were done in 2016?
How many procedures were done historically?
How many procedures can we expect in 2023 and what is the growth trend?

The European market for dental biomaterials includes dental bone graft substitutes, dental growth factors and dental barrier membranes. The level of development of the dental implant market within a given country highly dictates the corresponding size and growth of the DBGS market within that region. As the patient demand for dental implant procedures increases, the potential number of cases that require a bone grafting procedure also increases. This in turn generates demand for dental bone graft substitutes, barrier membranes and the dental growth factor product, Emdogain?.